Safety Profile of Amnion-Derived Cellular Cytokine Solution (ACCS) Following Topical Skin Application in Patients Receiving Breast Radiotherapy.

PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol (1990) 3.04

Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int J Radiat Oncol Biol Phys (2007) 2.40

A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs. Nat Biotechnol (2007) 2.35

"Cytokine storm" in the phase I trial of monoclonal antibody TGN1412: better understanding the causes to improve preclinical testing of immunotherapeutics. J Immunol (2007) 2.11

Monoclonal antibody TGN1412 trial failure explained by species differences in CD28 expression on CD4+ effector memory T-cells. Br J Pharmacol (2010) 1.65

Dose, time and fractionation: a clinical hypothesis. Clin Radiol (1969) 1.63

Scientific and regulatory considerations on the immunogenicity of biologics. Trends Biotechnol (2006) 1.21

TGN1412: From Discovery to Disaster. J Young Pharm (2010) 1.16

Pure red-cell aplasia due to anti-erythropoietin antibodies. Nephrol Dial Transplant (2003) 1.15

Amnion-derived cellular cytokine solution: a physiological combination of cytokines for wound healing. Eplasty (2008) 1.12

Safety of biologics, lessons learnt from TGN1412. Curr Opin Biotechnol (2009) 1.12

The use of amnion-derived cellular cytokine solution to improve healing in acute and chronic wound models. Eplasty (2008) 0.97

The effect of treatment interruptions in the postoperative irradiation of breast cancer. Oncology (2005) 0.95

Immune response against therapeutic factor VIII in hemophilia A patients--a survey of probable risk factors. Immunol Lett (2007) 0.91

The use of amnion-derived cellular cytokine solution (ACCS) in accelerating closure of interstices in explanted meshed human skin grafts. Eplasty (2009) 0.90

Human amnion-derived multipotent progenitor cell treatment alleviates traumatic brain injury-induced axonal degeneration. J Neurotrauma (2009) 0.85

Amnion-derived cellular cytokine solution promotes macrophage activity. Ann Plast Surg (2011) 0.84

Adverse drug reactions to biologics. J Dtsch Dermatol Ges (2010) 0.83

The effect of amnion-derived cellular cytokine solution on the epithelialization of partial-thickness donor site wounds in normal and streptozotocin-induced diabetic swine. Eplasty (2009) 0.82

Effect of amnion-derived cellular cytokine solution on healing of experimental partial-thickness burns. World J Surg (2010) 0.80